Skip to content
This GLP
Updated September 2026Priced by the day

TRYM Health review

The menu leads to a daily rate, and the daily rate belongs to a twelve-month plan.

The verdict

TRYM advertises plans from $3.20 a day for semaglutide and $4.20 for tirzepatide, which multiply out to $96 and $126 a month. Neither is a rate TRYM charges. Both are the twelve-month prepayments, and the month-to-month plans are $150 and $180.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
From
From $150/mo
Dose published
Yes
Prescription
Required
Compounded
Yes — not FDA-approved
Pharmacy
Not named
Availability
All 50 states

TRYM Health is a subscription management platform offering compounded semaglutide and tirzepatide alongside NAD+, a growth-hormone peptide and an amino blend. It states that it does not itself provide medical or pharmacy services. Programs are available in all fifty states.

  1. Who writes the prescription, and what do they see?

    There is no consultation step in the sign-up TRYM describes. A member registers, completes an intake form, pays, and is then matched with a partner provider for review. The platform presents skipping appointments as a convenience, so what the provider sees before approving an order is the form and nothing else.

    Programs are bought as terms of one, three, six or twelve months, each shipped in insulated packaging with a temperature sensor. The twelve-month plan arrives as two shipments rather than one. A patient already on a higher dose is told they will not have to start over.

  2. What happens when the dose goes up?

    Each program states that it fills enough supply to move up every four weeks on a regular dosing schedule. That is a clear commitment to covering the ladder inside one price. The pricing page also says both programs cover up to a maximum dose of 15 mg a week. That ceiling belongs to tirzepatide; the semaglutide entry carries the same sentence, and TRYM's services page caps semaglutide far lower.

  3. What the price includes

    The full table is published only on a pricing page the site's own navigation does not link to. That is the heart of the problem, because the menu reaches per-day figures and an account wall. Reached directly, it lists semaglutide at $150 a month, $375 a quarter, $650 for six months and $1,150 for a year, with tirzepatide at $180, $450, $800 and $1,500. TRYM states there are no membership fees, shipping costs or hidden charges.

  4. What it claims, and what it cites

    Both lines are compounded and described as additive free with a one-year expiry. TRYM states that compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality. The dispensing pharmacy is not named.

Where it holds up, and where it does not

  • Strength: The month-to-month rate is published, once the page is found
  • Strength: No membership fee or shipping charge
  • Strength: Supply is stated as covering a step every four weeks
  • Strength: A patient on a higher dose is not made to restart
  • Strength: Shipments are temperature-monitored
  • Limitation: The advertised daily rate is the twelve-month plan
  • Limitation: The pricing page is not linked from the navigation
  • Limitation: The semaglutide program states a tirzepatide dose ceiling
  • Limitation: Payment comes before any provider review

What the evidence says about this kind of treatment

The assessment above is about TRYM Health. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A buyer who will find the plan table and compare terms rather than days.
Wrong for
A buyer pricing a program from the per-day figure on the homepage.

How TRYM Health compares

SellerWho it suitsGo
Yucca HealthBuyers who want the whole ladder visible before intake and may not stay six monthsSee Yucca Health
Ondra HealthBuyers who want the billed total printed beside the monthly figure before they choose a termSee Ondra Health
Fifty 410Buyers who want no card charged until a prescription exists and will check which product a headline belongs toSee Fifty 410
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: IvologistJoi + BlokesJune HealthKERNX HealthKin MedsLaSara Medical Group

Sponsored alternative

Bodybuilding Health+

Readers who want to start without committing a year of money

Check Bodybuilding Health+ availability →

Frequently asked

Is $3.20 a day the real rate?
Only on the twelve-month plan. Month to month, semaglutide is $150 and tirzepatide is $180.
Where is the full price list?
On the pricing page, which the site's navigation does not link to. The menu leads instead to per-day figures and an account wall.
What dose do the programs cover?
The pricing page states both cover up to 15 mg a week. That is the tirzepatide ceiling, and TRYM's services page gives semaglutide a much lower one.
Is TRYM Health legit?
TRYM Health is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
Is TRYM Health expensive compared with other GLP-1 telehealth sellers?
TRYM Health publishes a starting figure of $150/mo. Across the 225 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $399 with a median of $179, which puts TRYM Health below the median, toward the cheaper end. The other 18 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Dana SullivanEvidence reviewer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from TRYM Health’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.